KRON Stock KRON is expected to report earnings to fall -3.49% to -44 cents per share on May 08

A.I.dvisor
at Tickeron.com
05/07/24
Loading...
KRON - Kronos Bio
Kronos Bio Earnings Graph
Q1'24
Est.
$-0.44
Q4'23
Beat
by $0.09
Q3'23
Missed
by $0.03
Q2'23
Missed
by $0.06
Q1'23
Missed
by $0.02
The last earnings report on December 31 showed earnings per share of -43 cents, beating the estimate of -52 cents. P/B Ratio (0.389) is normal, around the industry mean (10.333). P/E Ratio (0.000) is within average values for comparable stocks, (113.052). KRON's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.445). KRON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (9.461) is also within normal values, averaging (208.102). With 222.90K shares outstanding, the current market capitalization sits at 61.90M.
View a ticker or compare two or three
KRONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1300 So. El Camino Real
Phone
+1 650 781-5200
Employees
62
Web
https://www.kronosbio.com